USX:ELEV - Elevation Oncology, Inc. Common stock Elevation Oncology, Inc. Commo
Sector: Health Care, Industry: Biotechnology
Add to Watchlist
   
Add Alert 


Yahoo Finance

USD 8.2    +0.100 (+1.23%)
Show Technical Chart | 1M    3M    6M    1Y    3Y    5Y         

30 Jul 2021


Loading...
Loading...
Loading...

General

Headquarters: US

Description

Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be therapeutically actionable through targeted HER3 inhibition.